neuromodulation

A nerve cell affected by Alzheimer's disease
By  Dave Muoio 02:25 pm March 10, 2021
Yesterday Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, announced Phase 2 trial results suggesting its gamma frequency neuromodulation therapy slowed declines in memory and cognition among mild-to-moderate Alzheimer's disease patients. The OVERTURE study, a multi-center, randomized controlled trial, enrolled 76 such patients aged 50...
By  Dave Muoio 01:38 pm March 8, 2021
Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive adjustments from their provider via a cellular or WiFi connection. The NeuroSphere Virtual Clinic was recently approved by the FDA and is now available within the Abbott patient controller app for use with...
By  Dave Muoio 02:56 pm July 24, 2020
Abbott has received FDA approval for a neuromodulation system-controller app that runs on iOS devices, the company announced Thursday. Compatible with Abbott's broader NeuroSphere Digital Care platform, the Patient Controller app replaces the separate device patients use to adjust the company's neuromodulation products. These include the Infinity DBS System for Parkinson's disease or essential...
By  Dave Muoio 12:03 pm May 21, 2019
Cala Health, a wearable neuromodulation therapy startup focused on chronic diseases, has closed a $50 million Series C financing round. Novartis, Baird Capital, LifeSci Venture Partners, TriVentures and other unnamed backers participated, as did returning investors JJDC, Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital and GV. WHAT THEY DO Stanford University...
By  Jonah Comstock 11:38 am December 14, 2015
Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, movement disorders, and incontinence. The two companies partnered in June on diabetes around the same time Medtronic received FDA clearance for its MiniMed Connect device that connects Medtronic CGMs...